Top Markets
#1 Glidr Glidr +45.67%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.65%
#3 Movement Movement +9.79%
#4 Victoria VR Victoria VR +7.64%
#5 DMT-NAT DMT-NAT +7.02%
#6 Pons Pons +6.47%
#7 MarsCoin MarsCoin +5.30%
#8 Cryptopia Cryptopia +5.23%
#9 Lisk Lisk +5.01%
#10 Jito Jito +4.63%
Coin of the day
Glidr Glidr
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.

Timber Pharmaceuticals, Inc.

TMBR
Rang in aandelen #42059
Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical... Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the research, development, and market introduction of treatments for rare dermatological conditions. The company's key product candidates include: TMB-001, a patented topical isotretinoin formulation, which has successfully completed Phase 2b clinical trials. It is designed to address moderate to severe forms of Congenital Ichthyosis (CI), a group of uncommon genetic disorders affecting skin keratinization. TMB-002, a proprietary topical rapamycin, currently undergoing Phase 2b clinical trials. This therapy targets facial angiofibroma associated with Tuberous Sclerosis Complex, a complex genetic disorder characterized by the growth of benign tumors in multiple organs. TMB-003, a unique Sitaxsentan formulation functioning as a selective endothelin-A receptor antagonist, which is in preclinical development for various sclerotic skin diseases. Additionally, through a licensing agreement with AFT Pharmaceuticals Limited, Timber Pharmaceuticals is advancing two topical minocycline therapies: BPX-01, now in Phase 3 development for treating inflammatory lesions of acne vulgaris. BPX-04, which is prepared for Phase 3 trials, targeting papulopustular rosacea. Founded in 2019, Timber Pharmaceuticals is headquartered in Basking Ridge, New Jersey.
Aandeelprijs
$0.0101
Laatst gesynchroniseerd: 2023-12-26
Marktkapitalisatie
$5.32K
Verandering (1 dag)
741.67%
Verandering (1 jaar)
0.00%
Land
US
Handel Timber Pharmaceuticals, Inc. (TMBR)

Categorie

Healthcare
Prijs TMBR met de marktkapitalisatie van B
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
TMBR
$0.0101
Marktkapitalisatie van Timber Pharmaceuticals, Inc.(TMBR)
Marktkapitalisatie: $5.32K
Vanaf August 2026 heeft Timber Pharmaceuticals, Inc. een marktkapitalisatie van $5.32K. Dit maakt Timber Pharmaceuticals, Inc. volgens onze gegevens het 42059th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Timber Pharmaceuticals, Inc. van 2014 tot 2026
TMBR vergeleken met de top 5 populairste stocks
Prijs voor TMBR Aandeel B Marktkapitalisatie van B uitslagen
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$10,227,038 $5.32K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +101,257,803,053.34%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$8,403,338 $5.32K
Apple Inc. Apple Inc.
AAPL
$4.423T +83,201,368,693.29%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$7,903,663 $5.32K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +78,254,084,322.11%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$6,959,394 $5.32K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +68,904,895,245.87%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$5,492,612 $5.32K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +54,382,301,214.11%